Acumen Pharmaceuticals
ABOS
#9123
Rank
โ‚น10.44 B
Marketcap
โ‚น172.49
Share price
-1.03%
Change (1 day)
-9.45%
Change (1 year)

Revenue for Acumen Pharmaceuticals (ABOS)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acumen Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น27.57 M